Literature DB >> 6870519

Percutaneous splenic artery occlusion for portal hypertension. A new mechanical technique for hypersplenism.

G Zannini, S Masciariello, G Pagano, P Sangiuolo, G Zotti, V Iaccarino.   

Abstract

We studied 16 patients with hypersplenism, splenomegaly, and moderate nonbleeding portal hypertension with the purpose of discovering a hyperdynamic component associated with splenomegaly. We treated the patients' splenic hyperdynamic component and hypersplenism with a splenectomy. We measured wedge hepatic vein pressure (WHVP) before and after superior mesenteric artery occlusion by a balloon catheter, and after splenic artery (SA) occlusion by a balloon catheter. In 11 patients, following SA temporary occlusion an average WHVP reduction of 10.4 cm saline was obtained, and SA occlusion by Gianturco's coils was performed to obtain a gradual and segmentary occlusion. No colliquative phenomena were observed, and a stable decrease of WHVP with a marked improvement of peripheral cytopenia was obtained.

Entities:  

Mesh:

Year:  1983        PMID: 6870519     DOI: 10.1001/archsurg.1983.01390080005001

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

1.  Current concepts in portal hypertension.

Authors:  L R Del Guercio; M N Kinkhabwalla; H L Berman
Journal:  Bull N Y Acad Med       Date:  1985-10

2.  Partial splenic embolization: experience in 136 patients.

Authors:  O Jonasson; D G Spigos; M F Mozes
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

3.  Partial splenic embolization: long-term outcome.

Authors:  Birger Pålsson; Magnus Hallén; Annika Mandahl Forsberg; Anders Alwmark
Journal:  Langenbecks Arch Surg       Date:  2003-01-15       Impact factor: 3.445

4.  Partial splenectomy in cystic fibrosis patients with hypersplenism.

Authors:  G H Thalhammer; E Eber; S Uranüs; J Pfeifer; M S Zach
Journal:  Arch Dis Child       Date:  2003-02       Impact factor: 3.791

5.  [Portal hypertension].

Authors:  H Denck
Journal:  Langenbecks Arch Chir       Date:  1984
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.